Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | SP600125 |
| Trade Name | |
| Synonyms | |
| Drug Descriptions |
SP600125 is an ATP-competitive inhibitor of JNK, with activity against JNK1, JNK2, and JNK3 and also TTK (Mps1), which may lead to cell-cycle inhibition and decreased growth of tumor cells (PMID: 19478553, PMID: 11717429, PMID: 16113653, PMID: 32835935). |
| DrugClasses | JNK Inhibitor 5 MPS1 Inhibitor 27 |
| CAS Registry Number | 129-56-6 |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Cetuximab + SP600125 | Cetuximab SP600125 | 0 | 0 |
| Paclitaxel + SP600125 | Paclitaxel SP600125 | 0 | 0 |
| SP600125 | SP600125 | 1 | 0 |